Back
Reshape Lifesciences Stock Price Chart
Zero Day Options Trade LIVE Tuesday at 2 p.m. ET!
Discover The Zero Day Loophole (BEFORE Tues at 2 p.m. ET!)
Sell
16
RSLS
Reshape Lifesciences
Last Price:
4.73
Seasonality Move:
-9%
7 Day Trial
ALL ACCESS PASS
$
7
Better Than Oil Stocks
CLICK HERE TO FIND OUT MORE- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RSLS is experiencing slight buying pressure.
Reshape Lifesciences Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 5.17 | Sell |
| 20-day SMA: | 5.36 | Sell |
| 50-day SMA: | 5.47 | Sell |
| 200-day SMA: | 9.18 | Sell |
| 8-day EMA: | 5.13 | Sell |
| 20-day EMA: | 5.34 | Sell |
| 50-day EMA: | 5.9 | Sell |
| 200-day EMA: | 29.09 | Sell |
Reshape Lifesciences Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.2 | Sell |
| Relative Strength Index (14 RSI): | 37.81 | Sell |
| Chaikin Money Flow: | 11025 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (5.09 - 5.71) | Sell |
| Bollinger Bands (100): | (5.08 - 9.78) | Sell |
Reshape Lifesciences Technical Analysis
| Nov 27 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 27 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Reshape Lifesciences Stock
Is Reshape Lifesciences Stock a Buy?
- Reshape Lifesciences share price is 4.83 while RSLS 8-day simple moving average is 5.17, which is a Sell signal.
- The stock price of RSLS is 4.83 while Reshape Lifesciences 20-day SMA is 5.36, which makes it a Sell.
- Reshape Lifesciences 50-day simple moving average is 5.47 while RSLS share price is 4.83, making it a Sell technically.
- RSLS stock price is 4.83 and Reshape Lifesciences 200-day simple moving average is 9.18, creating a Sell signal.
RSLS Technical Analysis vs Fundamental Analysis
Sell
16
Reshape Lifesciences (RSLS)
is a Sell
Is Reshape Lifesciences a Buy or a Sell?
-
Reshape Lifesciences stock is rated a Sell
The current Reshape Lifesciences [RSLS] share price is $4.83. The Score for RSLS is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.
Reshape Lifesciences Stock Info
Market Cap:
3.44M
Price in USD:
4.83
Share Volume:
44.1K
Reshape Lifesciences 52-Week Range
52-Week High:
34.22
52-Week Low:
4.60
Sell
16
Reshape Lifesciences (RSLS)
is a Sell
Reshape Lifesciences Share Price Forecast
-
What is the Reshape Lifesciences stock price today?
The Reshape Lifesciences stock price is 4.83 USD today. -
Will RSLS stock go up or go down?
Reshape Lifesciences> share price is forecast to RISE/FALL based on technical indicators -
Is Reshape Lifesciences overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Reshape Lifesciences is overvalued.
Is Reshape Lifesciences Stock a Buy?
- Reshape Lifesciences share price is 4.83 while RSLS 8-day exponential moving average is 5.13, which is a Sell signal.
- The stock price of RSLS is 4.83 while Reshape Lifesciences 20-day EMA is 5.34, which makes it a Sell.
- Reshape Lifesciences 50-day exponential moving average is 5.90 while RSLS share price is 4.83, making it a Sell technically.
- RSLS stock price is 4.83 and Reshape Lifesciences 200-day simple moving average is 29.09, creating a Sell signal.
Fundamental Analysis of Reshape Lifesciences
Is Reshape Lifesciences a good investment?
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and an increase next year of $0.09 per share.
Technical Analysis of Reshape Lifesciences
Should I short Reshape Lifesciences stock?
- RSLS Moving Average Covergence Divergence (MACD) indicator is -0.2, suggesting Reshape Lifesciences is a Sell
- Reshape Lifesciences Relative Strength Index (RSI) is 37.81, which suggest Reshape Lifesciences is oversold
- The Bollinger Bands (25) for Reshape Lifesciences is (5.09 - 5.71), which suggest Reshape Lifesciences is a Sell
- The Bollinger Bands (100) for Reshape Lifesciences is (5.08 - 9.78), which suggest Reshape Lifesciences is a Sell
* Reshape Lifesciences stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.